Pioneering gene therapies for rare diseases
bluebird bio (bluebirdbio.com) scores 57 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, in the 4th percentile of 9941 Healthcare brands.
bluebird bio is a biotechnology company headquartered in Cambridge, United States, founded in 1992. It develops one-time, potentially curative gene therapies aimed at addressing the underlying genetic causes of severe, rare genetic diseases. The company positions itself as a pioneer in gene therapy innovation, targeting patients and families affected by these conditions, as well as the healthcare providers and researchers who treat and study them.
| Brand Name | bluebird bio |
|---|---|
| Domain | bluebirdbio.com |
| Industry | Healthcare |
| Founded | 1992 |
| Headquarters | Cambridge |
| Main Competitors | CRISPR Therapeutics (79/100), Sarepta Therapeutics (83/100), Novartis (AveXis) (71/100), Vertex Pharmaceuticals (88/100), Regenxbio, uniQure, Editas Medicine (82/100), Sangamo Therapeutics (84/100) |
Moz Domain Authority 57/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #892,531 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "To transform the lives of patients with severe genetic diseases through innovative gene therapies." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Apache.
Social footprint: verified profiles on X (Twitter), LinkedIn, Instagram; no detected presence on Facebook, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is bluebird bio?", Claude could identify the brand as of September 2026. bluebird bio is a biotechnology company specializing in gene therapies for severe genetic diseases, including sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy. It developed products like Zynteglo, Skysona, and Lyfgenia, which use lentiviral vector technolo Best known for Pioneering gene therapies for rare genetic blood disorders like sickle cell disease and beta-thalassemia.
When asked "Best brands similar to bluebird bio?", Claude would recommend bluebird bio as of September 2026. It's a notable name in gene therapy for genetic diseases, so it would come up naturally alongside companies like Vertex Pharmaceuticals or CRISPR Therapeutics in that space.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
bluebird bio's main competitors in Healthcare: CRISPR Therapeutics (79/100), Sarepta Therapeutics (83/100), Novartis (AveXis) (71/100), Vertex Pharmaceuticals (88/100), Editas Medicine (82/100).
Sources: Brand Analyzer scan
bluebird bio has limited AI-search visibility, scoring 31/100 on Brand Analyzer's AI visibility composite (visibility 28, trust 29, recommendation 40). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: bluebird bio official site
bluebird bio was founded in 1992. bluebird bio operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
bluebird bio is headquartered in Cambridge. bluebird bio operates in the Healthcare category.
Sources: Wikidata
bluebird bio scores 40/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: bluebird bio official site
bluebird bio is a biotechnology company based in Cambridge, United States, founded in 1992. It focuses on developing gene therapies for severe genetic diseases, aiming to address the underlying genetic causes of these conditions through one-time, potentially curative treatments.
Sources: bluebird bio official site
bluebird bio develops gene therapies designed to treat severe, rare genetic diseases by targeting the underlying genetic causes of these conditions. Its therapies are intended to be one-time, potentially curative treatments, offering an alternative to traditional ongoing treatment approaches for patients affected by these disorders.
Sources: bluebird bio official site
bluebird bio can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: bluebird bio official site
bluebird bio offers gene therapies designed to treat severe genetic diseases. These therapies are developed as one-time treatments intended to address the underlying genetic causes of rare conditions, differing from traditional ongoing treatment methods.
Sources: bluebird bio official site
bluebird bio's therapies and services are intended for patients and families affected by severe genetic diseases, as well as the healthcare providers and researchers who diagnose, treat, and study these conditions.
Sources: bluebird bio official site
bluebird bio is known for its work in gene therapy, specifically for developing one-time, potentially curative treatments aimed at severe genetic diseases. The company positions itself as a pioneer in this field, working to transform the lives of patients through innovative therapeutic approaches.
Sources: bluebird bio official site
bluebird bio scores 31/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
bluebird bio has a weak AI-visibility profile at 31/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (40/100) and its weakest is visibility (28/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #892,531 (Tranco) and a Moz Domain Authority of 57/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify bluebird bio from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to bluebird bio: BeWell Company (57/100), BCA Life (57/100), Body Labs (57/100), CarexTech (57/100).
A step up - brands to learn from: ZT Corporate (71/100), Zorgnet-Icuro (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.